Australian CVD Risk Calculator - Local Development build (vIteration3) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Draft as of 2025-05-19 |
@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
# - resource -------------------------------------------------------------------
a fhir:ValueSet ;
fhir:nodeRole fhir:treeRoot ;
fhir:id [ fhir:v "AusCVDRiskLipidModifyingMedicine-1"] ; #
fhir:text [
fhir:status [ fhir:v "generated" ] ;
fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet AusCVDRiskLipidModifyingMedicine-1</b></p><a name=\"AusCVDRiskLipidModifyingMedicine-1\"> </a><a name=\"hcAusCVDRiskLipidModifyingMedicine-1\"> </a><a name=\"AusCVDRiskLipidModifyingMedicine-1-en-AU\"> </a><ul><li>Include codes from<a href=\"http://www.snomed.org/\"><code>http://snomed.info/sct</code></a> where constraint = ( ( ((^929360061000036106|MP | AND << (108600003 |Atorvastatin| OR 96307003 |Fluvastatin| OR 96305006 |Pravastatin| OR 96304005 |Simvastatin| OR 319982006 |Acipimox-containing product| OR 319937007 |Bezafibrate-containing product| OR 72824008 |Colestyramine| OR 77035009 |Clofibrate| OR 66971004 |Colestipol-containing product| OR 408041006 |Ezetimibe| OR 35282000 |Gemfibrozil| OR 63639004 |Nicotinic acid|)) OR (<<^929360071000036103|MPUU | AND << (108600003 |Atorvastatin| OR 96307003 |Fluvastatin| OR 96305006 |Pravastatin| OR 96304005 |Simvastatin| OR 319982006 |Acipimox-containing product| OR 319937007 |Bezafibrate-containing product| OR 72824008 |Colestyramine| OR 77035009 |Clofibrate| OR 66971004 |Colestipol-containing product| OR 408041006 |Ezetimibe| OR 35282000 |Gemfibrozil| OR 63639004 |Nicotinic acid|)) OR (<<^ 929360081000036101|MPP Refset|: { 774160008 | Contains clinical drug (attribute) | = << (108600003 |Atorvastatin| OR 96307003 |Fluvastatin| OR 96305006 |Pravastatin| OR 96304005 |Simvastatin| OR 319982006 |Acipimox-containing product| OR 319937007 |Bezafibrate-containing product| OR 72824008 |Colestyramine| OR 77035009 |Clofibrate| OR 66971004 |Colestipol-containing product| OR 408041006 |Ezetimibe| OR 35282000 |Gemfibrozil| OR 63639004 |Nicotinic acid|) }) OR (( ( <<^929360071000036103|MPUU | AND << (108600003 |Atorvastatin| OR 96307003 |Fluvastatin| OR 96305006 |Pravastatin| OR 96304005 |Simvastatin| OR 319982006 |Acipimox-containing product| OR 319937007 |Bezafibrate-containing product| OR 72824008 |Colestyramine| OR 77035009 |Clofibrate| OR 66971004 |Colestipol-containing product| OR 408041006 |Ezetimibe| OR 35282000 |Gemfibrozil| OR 63639004 |Nicotinic acid|) ) OR (<<^ 929360081000036101|MPP Refset|: { 774160008 | Contains clinical drug (attribute) | = << (108600003 |Atorvastatin| OR 96307003 |Fluvastatin| OR 96305006 |Pravastatin| OR 96304005 |Simvastatin| OR 319982006 |Acipimox-containing product| OR 319937007 |Bezafibrate-containing product| OR 72824008 |Colestyramine| OR 77035009 |Clofibrate| OR 66971004 |Colestipol-containing product| OR 408041006 |Ezetimibe| OR 35282000 |Gemfibrozil| OR 63639004 |Nicotinic acid|) } ) ) .774158006 |Has product name|)) ) ) MINUS ( ( ((<< 1145021005 |Vitamin-containing product|) OR (<<^ 929360081000036101|MPP|: { 774160008|Contains clinical drug| = << 1145021005 |Vitamin-containing product| }) OR (( ( << 1145021005 |Vitamin-containing product| ) OR (<<^ 929360081000036101|MPP|: { 774160008|Contains clinical drug| = << 1145021005 |Vitamin-containing product| } ) ) .774158006 |Has product name|)) ) )</li></ul></div>"^^rdf:XMLLiteral
] ; #
fhir:url [ fhir:v "https://www.cvdcheck.org.au/fhir/ValueSet/AusCVDRiskLipidModifyingMedicine-1"^^xsd:anyURI] ; #
fhir:version [ fhir:v "Iteration3"] ; #
fhir:name [ fhir:v "AusCVDRiskLipidModifyingMedicine"] ; #
fhir:title [ fhir:v "Aus CVD Risk Lipid Modifying Medicine"] ; #
fhir:status [ fhir:v "draft"] ; #
fhir:experimental [ fhir:v false] ; #
fhir:date [ fhir:v "2025-05-19T11:57:09+10:00"^^xsd:dateTime] ; #
fhir:publisher [ fhir:v "National Heart Foundation of Australia"] ; #
fhir:contact ( [
fhir:name [ fhir:v "National Heart Foundation of Australia" ] ;
( fhir:telecom [
fhir:system [ fhir:v "url" ] ;
fhir:value [ fhir:v "https://www.heartfoundation.org.au/" ] ] )
] ) ; #
fhir:description [ fhir:v "The Aus CVD Risk Lipid Modifying Medicine value set includes Australian Medicines Terminology products classified as lipid modifying according to the Australian guideline for assessing and managing cardiovascular disease risk."] ; #
fhir:jurisdiction ( [
( fhir:coding [
fhir:system [ fhir:v "urn:iso:std:iso:3166"^^xsd:anyURI ] ;
fhir:code [ fhir:v "AU" ] ;
fhir:display [ fhir:v "Australia" ] ] )
] ) ; #
fhir:copyright [ fhir:v "Copyright © 2024+ National Heart Foundation of Australia - All rights reserved. This content is not available under an open source licence."] ; #
fhir:compose [
( fhir:include [
fhir:system [ fhir:v "http://snomed.info/sct"^^xsd:anyURI ] ;
fhir:version [ fhir:v "http://snomed.info/sct/32506021000036107" ] ;
( fhir:filter [
fhir:property [ fhir:v "constraint" ] ;
fhir:op [ fhir:v "=" ] ;
fhir:value [ fhir:v "( ( ((^929360061000036106|MP | AND << (108600003 |Atorvastatin| OR 96307003 |Fluvastatin| OR 96305006 |Pravastatin| OR 96304005 |Simvastatin| OR 319982006 |Acipimox-containing product| OR 319937007 |Bezafibrate-containing product| OR 72824008 |Colestyramine| OR 77035009 |Clofibrate| OR 66971004 |Colestipol-containing product| OR 408041006 |Ezetimibe| OR 35282000 |Gemfibrozil| OR 63639004 |Nicotinic acid|)) OR (<<^929360071000036103|MPUU | AND << (108600003 |Atorvastatin| OR 96307003 |Fluvastatin| OR 96305006 |Pravastatin| OR 96304005 |Simvastatin| OR 319982006 |Acipimox-containing product| OR 319937007 |Bezafibrate-containing product| OR 72824008 |Colestyramine| OR 77035009 |Clofibrate| OR 66971004 |Colestipol-containing product| OR 408041006 |Ezetimibe| OR 35282000 |Gemfibrozil| OR 63639004 |Nicotinic acid|)) OR (<<^ 929360081000036101|MPP Refset|: { 774160008 | Contains clinical drug (attribute) | = << (108600003 |Atorvastatin| OR 96307003 |Fluvastatin| OR 96305006 |Pravastatin| OR 96304005 |Simvastatin| OR 319982006 |Acipimox-containing product| OR 319937007 |Bezafibrate-containing product| OR 72824008 |Colestyramine| OR 77035009 |Clofibrate| OR 66971004 |Colestipol-containing product| OR 408041006 |Ezetimibe| OR 35282000 |Gemfibrozil| OR 63639004 |Nicotinic acid|) }) OR (( ( <<^929360071000036103|MPUU | AND << (108600003 |Atorvastatin| OR 96307003 |Fluvastatin| OR 96305006 |Pravastatin| OR 96304005 |Simvastatin| OR 319982006 |Acipimox-containing product| OR 319937007 |Bezafibrate-containing product| OR 72824008 |Colestyramine| OR 77035009 |Clofibrate| OR 66971004 |Colestipol-containing product| OR 408041006 |Ezetimibe| OR 35282000 |Gemfibrozil| OR 63639004 |Nicotinic acid|) ) OR (<<^ 929360081000036101|MPP Refset|: { 774160008 | Contains clinical drug (attribute) | = << (108600003 |Atorvastatin| OR 96307003 |Fluvastatin| OR 96305006 |Pravastatin| OR 96304005 |Simvastatin| OR 319982006 |Acipimox-containing product| OR 319937007 |Bezafibrate-containing product| OR 72824008 |Colestyramine| OR 77035009 |Clofibrate| OR 66971004 |Colestipol-containing product| OR 408041006 |Ezetimibe| OR 35282000 |Gemfibrozil| OR 63639004 |Nicotinic acid|) } ) ) .774158006 |Has product name|)) ) ) MINUS ( ( ((<< 1145021005 |Vitamin-containing product|) OR (<<^ 929360081000036101|MPP|: { 774160008|Contains clinical drug| = << 1145021005 |Vitamin-containing product| }) OR (( ( << 1145021005 |Vitamin-containing product| ) OR (<<^ 929360081000036101|MPP|: { 774160008|Contains clinical drug| = << 1145021005 |Vitamin-containing product| } ) ) .774158006 |Has product name|)) ) )" ] ] ) ] )
] . #
IG © 2024+ National Heart Foundation of Australia. Package health.au.fhir.cvdrisk#Iteration3 based on FHIR 4.0.1. Generated 2025-05-19
Links: Table of Contents |
QA Report